Individualising Antibiotic Dosing in Critically Ill Patients with Acute Kidney Injury: Pharmacokinetic and Pharmacodynamic Challenges
Acute kidney injury (AKI) is common in critically ill patients and alters the handling of renally cleared antibiotics, while sepsis adds unpredictable changes in volume of distribution, protein binding and organ perfusion. Renal dosing recommendations derived from stable chronic kidney disease can leave patients underexposed early in infection, whereas later drug accumulation drives neurotoxicity and nephrotoxicity. This review examines the pharmacokinetic and pharmacodynamic basis for individualised antibiotic dosing in AKI, compares loading with maintenance strategies, and considers the limits of creatinine-based estimates, renal replacement therapy, therapeutic drug monitoring and toxicity. Much of the supporting evidence is pharmacokinetic or observational, and randomised trials of dose adjustment in AKI are lacking. We therefore propose a stepwise framework for clinical judgement: full loading doses, prolonged β-lactam infusion, reassessment of maintenance doses at 24 to 48 hours, and concentration monitoring where available. Practical implications for Indian intensive care units and for clinical pharmacists are discussed.
Authors
- Abinash. K.
- Monica. K.
- Manisha. M.
Institutions
- Tamil Nadu Dr. M.G.R. Medical University (IN)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-20
- DOI
- https://doi.org/10.5281/zenodo.24394380
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 0.00